Abstract
AbstractDue to the many implemented restrictions, the SARS-CoV-2 pandemic has rendered some tasks more difficult, for instance, the evaluation of outpatients. Panama’s tertiary care hospital for kidney biopsy referral was transformed into a COVID-only hospital in order to assist the large number of COVID-19 patients. In order to face the impossibility of following patients with nephrotic or nephritic syndrome, a biopsy program was implemented in a southern province in Panama. Thirty kidney biopsies were carried out over a 1-year period. This experience shows that kidney biopsy programs, that are usually run only in large referral centers, can also be implemented in small nephrology centers, allowing to obtain accurate diagnoses and to guide correct treatment.
Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Loutradis C, Pitoulias AG, Pagkopoulou E, Pitoulias GA (2021) Cardiovascular complications after COVID-19 in chronic kidney disease, dialysis and kidney transplant patients. Int Urol Nephrol. https://doi.org/10.1007/s11255-021-03059-3 (published online ahead of print, 2021 Nov 22)
2. Giraldo E, Williams R, Bustamante N, Courville K, Viggiano C, Milord R. Estadísticas de biopsias renales realizadas en el Complejo Hospitalario Dr. Arnulfo Arias Madrid. Panamá 2005–2007. IV Congreso Nacional de Nefrología e Hipertensión 18 y 19 de septiembre de 2009, Cuidad de Panamá.
3. Hogan JJ, Mocanu M, Berns JS (2016) The native kidney biopsy: update and evidence for best practice. Clin J Am Soc Nephrol 11(2):354–362. https://doi.org/10.2215/CJN.05750515
4. Fogo AB (2003) Approach to renal biopsy. Am J Kidney Dis 42(4):826–836. https://pubmed.ncbi.nlm.nih.gov/14520635/
5. Šimunov B, Gunjača M, Čingel B, Škegro D, Knotek M (2018) Safety of outpatient kidney biopsies. Nephron 138(4):275–279. https://doi.org/10.1159/000484991